Table 2.
GnomAD variants in clinical genes for which the BIOS-trained model predicts ASE effects.
Gene | RsID/GRCh37 | MAF | Conseq. | ClinVar |
---|---|---|---|---|
BRCA2 | rs748508287 | 3.99E−06 | Stop gained | P*** |
BRCA2 | rs80358556 | 4.01E−06 | Stop gained | P*** |
BRCA2 | rs80358851 | 3.99E−06 | Stop gained | P*** |
BRCA2 | rs766337502 | 4.60E−06 | Intronic | – |
BRCA2 | rs753979600 | 4.56E−06 | Intronic | – |
BRCA2 | rs779588681 | 4.69E−06 | Intronic | – |
BRCA2 | rs80359003 | 7.95E−06 | Stop gained | P*** |
BRCA2 | rs776353983 (C>A) | 3.98E−06 | Stop gained | P*** |
NF1 | rs764079291 | 4.00E−06 | Stop gained | P** |
NF1 | rs1316926587 | 4.00E−06 | Stop gained | P* |
NF1 | rs761199437 | 0 | Stop gained | – |
NF1 | rs1282299543 | 0 | Stop gained | P* |
NF1 | rs376576925 (C>A) | 1.59E−05 | Synonymous | LB/VUS* |
NF1 | rs376576925 (C>T) | 3.98E−06 | Stop gained | P** |
NF1 | 17:29576138G>A | 3.98E−06 | Splice donor | P** |
NF1 | rs748461474 | 8.04E−06 | Intronic | – |
NF1 | rs776167625 | 4.02E−06 | Intronic | – |
NF1 | rs1481561333 | 4.02E−06 | Intronic | – |
NF1 | rs756300767 | 8.32E−06 | Intronic | – |
RET | rs754967305 | 3.12E−05 | Intronic | LB** |
RET | 10:43596200T>C | 0 | Intronic | – |
RET | rs1452567543 | 4.38E−05 | Intronic | – |
RET | rs1198523793 | 0 | Intronic | – |
RET | rs979417275 | 3.67E−05 | Intronic | – |
RET | rs1471253713 | 0 | Intronic | – |
RET | rs1476675800 | 0 | Stop gained | – |
RET | rs775711017 | 0 | Stop gained | – |
The ClinVar classifications shown are: P for Pathogenic, LB for Likely Benign, and VUS for Variant of Unknown Significance. The asterisks indicate the review status of ClinVar, where zero is the worst and four is the best. The MAF (Minor Allele Frequency) values are taken from GnomAD exomes r2.1.1. A MAF of zero means the variant was detected but there were no high-confidence genotype calls made. The RS identifiers are supplemented with base changes in ambiguous cases. GRCh37 coordinates are used if no RS identifiers exist for an SNV.